The renin–angiotensin system (RAS) is a highly regulated hormonal cascade that plays a central role in the control of blood pressure and the maintenance of renal homeostasis. Its components, including ...

The renin-angiotensin system (RAS) remains a cornerstone of cardiovascular and renal physiology, orchestrating vital aspects of blood pressure regulation and fluid-electrolyte balance. At the heart of ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Two new studies have been published that further focus attention on how the renin–angiotensin ...

New Orleans, La. (March 27, 2007) -- A combination of two medicines that act against the effects of the enzyme renin are more effective in lowering blood pressure than either of the medicines alone, ...

A new study compared the effects of renin-angiotensin-system inhibitor and calcium channel blocker therapy on the risks for kidney replacement therapy, major cardiovascular events, and death among ...

In this rapidly evolving setting, clinicians are weighing the alleged harm of continuing these medications in patients for whom ACE inhibitors and ARBs have known benefit against the harm to their ...

Please provide your email address to receive an email when new articles are posted on . RAS blockers had similar mortality benefit by race in patients with HFrEF. RAS blockers improved HF ...

In patients with mild or moderate chronic kidney disease, renin–angiotensin system inhibitors have improved outcomes, but less evidence supports their use in advanced CKD. New research findings are ...

"I feel better, but my mind isn't the same." Four years after the height of the COVID-19 pandemic, such comments are still heard regularly in many medical practices in South Africa. What began as a ...